Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3211 AL 3225

Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI

Michler E, Hoberück S, Martino F, Platzek I, Kotzerke J.

Nuklearmedizin. 2019 Sep;58(5):403-404. doi: 10.1055/a-0972-0698. Epub 2019 Jul 25.

Envisioning the neuroprotective effect of Metformin in experimental epilepsy: A portrait of molecular crosstalk

H S N, Paudel YN, K L K.

Life Sci. 2019 Sep 15;233:116686. doi: 10.1016/j.lfs.2019.116686. Epub 2019 Jul 23.

Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders

Antonazzo M, Botta M, Bengoetxea H, Ruiz-Ortega JÁ, Morera-Herreras T.

Int Rev Neurobiol. 2019;146:229-257. doi: 10.1016/bs.irn.2019.06.012. Epub 2019 Jun 28.

Systematic data analysis and data mining in CatWalk gait analysis by heat mapping exemplified in rodent models for neurodegenerative diseases

Timotius IK, Canneva F, Minakaki G, Moceri S, Plank AC, Casadei N, Riess O, Winkler J, Klucken J, Eskofier B, von Hörsten S.

J Neurosci Methods. 2019 Oct 1;326:108367. doi: 10.1016/j.jneumeth.2019.108367. Epub 2019 Jul 24.

Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations

Cepeda C, Oikonomou KD, Cummings D, Barry J, Yazon VW, Chen DT, Asai J, Williams CK, Vinters HV.

J Neurosci Res. 2019 Dec;97(12):1624-1635. doi: 10.1002/jnr.24503. Epub 2019 Jul 28.

Chorea

Termsarasab P.

Continuum (Minneap Minn). 2019 Aug;25(4):1001-1035. doi: 10.1212/CON.0000000000000763.

Movement Disorders in Children

Pearson TS, Pons R.

Continuum (Minneap Minn). 2019 Aug;25(4):1099-1120. doi: 10.1212/CON.0000000000000756.

Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review

Fernandes JG, Franco NH, Grierson AJ, Hultgren J, Furley AJW, Olsson IAS.

BMJ Open Sci. 2019 Aug 1;3(1):e000016. doi: 10.1136/bmjos-2018-000016. eCollection 2019.

Huntington's disease: a forensic risk factor in women

Chu EM, O'Neill M, Purkayastha DD, Knight C.

J Clin Mov Disord. 2019 Jul 24;6:3. doi: 10.1186/s40734-019-0078-x. eCollection 2019.

Huntington disease: When does it begin?

Martin WRW, Albin RL.

Neurology. 2019 Sep 3;93(10):421-422. doi: 10.1212/WNL.0000000000008054. Epub 2019 Aug 1.

Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae

Cunningham MW.

Microbiol Spectr. 2019 Jul;7(4):10.1128/microbiolspec.gpp3-0045-2018. doi: 10.1128/microbiolspec.GPP3-0045-2018.

The conserved ancestral signaling pathway from cilium to nucleus

Satir P, Satir BH.

J Cell Sci. 2019 Aug 2;132(15):jcs230441. doi: 10.1242/jcs.230441.

Lipid peroxidation in neurodegeneration

Peña-Bautista C, Vento M, Baquero M, Cháfer-Pericás C.

Clin Chim Acta. 2019 Oct;497:178-188. doi: 10.1016/j.cca.2019.07.037. Epub 2019 Aug 1.

What human blood-brain barrier models can tell us about BBB function and drug discovery?

Ferreira L.

Expert Opin Drug Discov. 2019 Nov;14(11):1113-1123. doi: 10.1080/17460441.2019.1646722. Epub 2019 Aug 6.

Proteasome Activation to Combat Proteotoxicity

Jones CL, Tepe JJ.

Molecules. 2019 Aug 5;24(15):2841. doi: 10.3390/molecules24152841.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias